<DOC>
	<DOC>NCT00336908</DOC>
	<brief_summary>This study is a blinded, randomized, controlled prospective trial comparing immune response (sepsis, inflammatory response, pulmonary vasoconstriction) in 2 groups of infants less than 3-month old receiving pre and post cardiopulmonary bypass surgery. The infants will receive 1 out of the 2 following intravenous lipid preparations: Soybean Oil (n-6), or a combination of Medium Chain Triglyceride i.e. coconut oil, Long Chain Triglyceride i.e. Soybean Oil, and Fish Oil (MCT:LCT:FO). There will be 16 subjects in each group.</brief_summary>
	<brief_title>Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<criteria>36 weeks gestation 3 months corrected age appropriate for gestational age (AGA) admitted for surgical correction of congenital heart defects (single ventricle, tetralogy of Fallot, truncus and complex biventricular repairs) enteral nutrition at 30 kcal/kilogram/day 5 minute Apgar score of 4 major congenital defect other than heart defect presence of significant neonatal morbidity (intraventricular hemorrhage (IVH) grade 3 or greater, necrotizing enterocolitis (NEC) and surgical abdomen) any metabolic disorder any endocrine disorder medications which alter eicosanoid metabolism including indomethacin, acetylsalicylate (with exception of steroids which will be analyzed independently)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Intensive Care,Neonatal</keyword>
	<keyword>Parenteral nutrition</keyword>
	<keyword>Fat emulsions,Intravenous</keyword>
</DOC>